Read + Share
Marth C, Moore RG, Bidzinski M, Pignata S, et al. First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced
Endometrial Cancer: A Randomized, Open-Label, Phase III Trial. J Clin Oncol 2025;43:1083-1100.
PMID: 39591551
|
 |
|
Marth C, Moore RG, Bidzinski M, Pignata S, et al. First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced
Endometrial Cancer: A Randomized, Open-Label, Phase III Trial. J Clin Oncol 2025;43:1083-1100.
PMID: 39591551
|
|
|
|